Supplements

Circadian rhythm disruption accelerates dopaminergic neurodegeneration in Parkinson's disease through four convergent mechanisms

This narrative review synthesizes evidence that circadian rhythm disruption (CRD) contributes to Parkinson's disease (PD) pathogenesis via four mechanisms: REV-ERBα-mediated dysregulation of dopamine biosynthesis and NF-κB/NLRP3 neuroinflammation, impaired sleep-dependent glymphatic clearance of α-synuclein, NAD+-SIRT1-BMAL1-PGC-1α axis dysfunction causing mitochondrial bioenergetic failure, and C/EBPβ-dependent autophagic rhythm disruption with pro-inflammatory microglial activation. These mechanisms collectively create a pro-inflammatory and autophagy-suppressive environment that promotes α-synuclein aggregation.

Last updated: Aug 23, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Bidirectional Mechanisms Linking Circadian Rhythm Disruption and Parkinson's Disease: Chronobiomarkers and Therapeutic Implications.

observational

Zhang X, Shen W, Wu Y, Zhang W, Ye Q · International journal of molecular sciences (2026)

Participants: N/A
Duration: N/A
Intervention: Not applicable (narrative review of mechanistic literature)
Outcome: Dopaminergic neurodegeneration, α-synuclein aggregation, neuroinflammation, mitochondrial function, autophagy
Effect Size: N/A
Population: Preclinical models and human studies of Parkinson's disease (as reviewed)

Result:

PubMed: 42589377DOI: 10.3390/ijms27156719

Mechanism Graph

REV-ERBα dysregulation reduces dopamine biosynthesis and activates NF-κB/NLRP3 inflammasome
↓
Impaired glymphatic clearance due to sleep disruption leads to α-synuclein accumulation
↓
NAD+-SIRT1-BMAL1-PGC-1α axis dysfunction impairs mitochondrial bioenergetics
↓
C/EBPβ-dependent autophagic rhythm disruption and microglial activation
↓
Result: Dual pro-inflammatory and autophagy-suppressive milieu permissive for α-synuclein aggregation and dopaminergic neurodegeneration

Limitations

  • ⚠Narrative review without systematic search or quantitative meta-analysis
  • ⚠Mechanistic evidence largely from animal models, with limited direct human confirmation
  • ⚠No effect sizes or risk of bias assessment provided

Frequently Asked Questions

How does circadian disruption contribute to Parkinson's disease?▼

Circadian disruption accelerates dopaminergic neurodegeneration through four mechanisms: REV-ERBα-mediated dopamine dysregulation and neuroinflammation, impaired glymphatic clearance of α-synuclein, mitochondrial dysfunction via NAD+-SIRT1-BMAL1-PGC-1α axis, and disrupted autophagy with microglial activation.

What are the four mechanisms linking circadian rhythm disruption to Parkinson's disease?▼

The four mechanisms are: (1) REV-ERBα-mediated dysregulation of dopamine biosynthesis and NF-κB/NLRP3 neuroinflammation, (2) impaired sleep-dependent glymphatic clearance of α-synuclein, (3) NAD+-SIRT1-BMAL1-PGC-1α axis dysfunction leading to mitochondrial bioenergetic failure, and (4) C/EBPβ-dependent autophagic rhythm disruption with pro-inflammatory microglial activation.

Is circadian disruption a cause or consequence of Parkinson's disease?▼

The paper suggests a bidirectional relationship: circadian disruption can drive PD pathogenesis, and PD pathology can destabilize circadian rhythms. This bidirectional interplay is considered both a prodromal feature and a pathogenic driver.

What chronobiomarkers are proposed for early Parkinson's disease diagnosis?▼

Emerging multi-modal chronobiomarkers include peripheral clock gene expression profiles, melatonin secretion patterns, tryptophan-kynurenine metabolites, and gut microbial oscillation signatures.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Zhang X, Shen W, Wu Y, Zhang W, Ye Q. "Bidirectional Mechanisms Linking Circadian Rhythm Disruption and Parkinson's Disease: Chronobiomarkers and Therapeutic Implications.." International journal of molecular sciences, 2026. PMID: 42589377 DOI: 10.3390/ijms27156719
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.